These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3088172)

  • 21. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatic encephalopathy: a clinical analysis of 107 cases].
    Wang XG
    Zhonghua Wai Ke Za Zhi; 1988 Jul; 26(7):396-9, 444-5. PubMed ID: 3229250
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of severe hyperammonemia].
    Leonhardt H; Bungert HJ
    Med Klin; 1972 Aug; 67(32):1052-6. PubMed ID: 5070916
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
    Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
    [No Abstract]   [Full Text] [Related]  

  • 26. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of intractable hepatic encephalopathy successfully treated by oral administration of vancomycin hydrochloride, with subsequent improvement of hepatic function reserve enabling transcatheter arterial chemoembolization against hepatocellular carcinoma].
    Kuzuya T; Takeda K; Utsunomiya S; Taga M; Kawata N; Ikeda T; Imai N; Mizutani Y; Hirose K; Ishikawa T
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):995-7. PubMed ID: 21677494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic encephalopathy].
    Kaku T; Shiba M; Yoshimasu F
    Nihon Rinsho; 2004 Jan; 62 Suppl():409-13. PubMed ID: 15011396
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vegetable protein diets with or without non-absorbable antibiotics for the treatment of chronic portal systemic encephalopathy].
    Uribe M; Vargas F; Villalobos A; Ramos GC; Briones A; Galvan E; Ramos MH; Guevara L
    Rev Invest Clin; 1990 Jul; 42 Suppl():120-6. PubMed ID: 19256150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
    Yamamoto HA; Sugihara N
    Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urease and deaminase activities of fecal bacteria in hepatic coma.
    Sabbaj J; Sutter VL; Finegold SM
    Antimicrob Agents Chemother (Bethesda); 1970; 10():181-5. PubMed ID: 5521334
    [No Abstract]   [Full Text] [Related]  

  • 32. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ammonia and inflammation in minimal hepatic encephalopathy.
    Shawcross DL; Wright G; Olde Damink SW; Jalan R
    Metab Brain Dis; 2007 Mar; 22(1):125-38. PubMed ID: 17260161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactulose enemas.
    Kersh ES; Rifkin H
    Ann Intern Med; 1973 Jan; 78(1):81-4. PubMed ID: 4682313
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy.
    Artz SA; Paes IC; Faloon WW
    Gastroenterology; 1966 Dec; 51(6):1046-53. PubMed ID: 5958605
    [No Abstract]   [Full Text] [Related]  

  • 39. [Propranolol, hepatic encephalopathy and blood levels of ammonia in hepatic cirrhosis].
    Errico M; Giacobbe A; Facciorusso D; Simone P; Conoscitore P; De Maio ; Spirito F
    Minerva Dietol Gastroenterol; 1987; 33(3):223-6. PubMed ID: 3670672
    [No Abstract]   [Full Text] [Related]  

  • 40. Lactulose: a drug in search of a modus operandi.
    Conn HO
    Gastroenterology; 1978 Mar; 74(3):624-6. PubMed ID: 24572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.